Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis

被引:0
作者
Lin-Yu Xia
Qing-Lin Hu
Qing Zhou
机构
[1] The First Affiliated Hospital of Chengdu Medical College,Department of Thyroid and Breast Surgery
来源
BMC Women's Health | / 21卷
关键词
Breast cancer; Pregnancy; Trastuzumab; Complication; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 154 条
[1]  
Waterston AM(2006)Effect of adjuvant trastuzumab on pregnancy J Clin Oncol 24 321-322
[2]  
Graham J(2006)Immunoglobulins-basic considerations J. Neurol. 253 V9-V17
[3]  
Mix E(2010)Fertility and pregnancy: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up Ann. Oncol. 21 v266-v273
[4]  
Goertsches R(1993)Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients Cancer 71 2499-169
[5]  
Zett UK(2014)Pregnancy associated breast cancer: an institutional experience Indian J. Cancer 51 167-798
[6]  
Pentheroudakis G(2010)The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer Cancer 116 791-370
[7]  
Orecchia R(2009)Safety of trastuzumab (Herceptin) during pregnancy: two case reports Cases J. 2 9329-1569
[8]  
Hoekstra HJ(2009)Breast cancer and pregnancy: How safe is trastuzumab? Nat. Rev. Clin. Oncol. 6 367-382
[9]  
Pavlidis N(2017)Trastuzumab exposure during pregnancy with Invasive Breast Cancer Perinatology 28 4-83
[10]  
Elledge RM(2008)Treatment of breast cancer with trastuzumab during pregnancy J. Clin. Oncol. 26 1567-81